18F-FDG PET/CT, 99mTc-MIBI, and MRI in the Prediction of Outcome of Patients With Multiple Myeloma: A Comparative Study. Fonti R et al. Clin Nucl Med. 2015 Jan 20. [Epub ahead of print]. Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement. Dimopoulos MA et al. J Clin Oncol. 2015 Jan 20. pii: JCO.2014.57.9961. [Epub…
Heavy/Light Chain Assay for Monitoring IgA Multiple Myeloma: Digging Out the IgA from the β Region. Calderon B et al. Clin Chem. 2014 Dec 10. pii: clinchem.2014.234757. [Epub ahead of print]. Dysregulated class I histone deacetylases are indicators of poor prognosis in multiple myeloma. Mithraprabhu S et al. Epigenetics. 2014 Dec 6:0. [Epub ahead of print]. Calorimetric markers of bence jones and nonsecretory multiple…
Comparison of cross-platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy. Mathis S et al. Cytometry B Clin Cytom. 2014 Nov 17. doi: 10.1002/cyto.b.21200. [Epub ahead of print]. Clinical Course and Prognosis of Non-Secretory Multiple Myeloma. Chawla SS et al. Eur J Haematol. 2014 Nov 10. doi: 10.1111/ejh.12478. [Epub ahead of print]. The prognostic value…
Comparison of cross-platform flow cytometry minimal residual disease evaluation in multiple myeloma using a common antibody combination and analysis strategy. Mathis S et al. Cytometry B Clin Cytom. 2014 Oct 28. doi: 10.1002/cytob.21200. [Epub ahead of print]. Early relapse after single auto-SCT for multiple myeloma is a major predictor of survival in the era of…
Flow cytometric sensitivity and characteristics of plasma cells in patients with multiple myeloma or its precursor disease: influence of biopsy site and anticoagulation method. Manasanch EE et al. Leuk Lymphoma. 2014 Sep 27:1-24. [Epub ahead of print]. Protein Expression for Novel Prognostic Markers (Cyclins D1, D2, D3, B1, B2, ITGβ7, FGFR3, PAX5) Correlate With Previously…
11C-PiB PET/CT in Nasopharyngeal Amyloidosis Associated with Multiple Myeloma. Ishimura M et al. Clin Nucl Med. 2014 Aug 19. [Epub ahead of print]. Absolute Lymphocyte Count Is Unrelated to Overall Survival in Newly Diagnosed Elderly Patients with Multiple Myeloma Treated with Immunomodulatory Drugs. Napolitano M et al. Leuk Lymphoma. 2014 Aug 20:1-10. [Epub ahead of…
Hepcidin and GDF15 in anemia of multiple myeloma. Mei S et al. Int J Hematol. 2014 Jul 23. [Epub ahead of print]. Altered cytokine and chemokine profiles in multiple myeloma and precursor disease. Zingone A et al. Cytokine. 2014 Jul 17. pii: S1043-4666(14)00150-1. doi: 10.1016/j.cyto.2014.05.017. [Epub ahead of print]. Detecting monoclonal light chains in urine:…
Predicting multiple myeloma disease activity by analyzing natural calcium isotopic composition. Gordon GW et al. Leukemia. 2014 Jun 12. doi: 10.1038/leu.2014.193. [Epub ahead of print]. Identification of cereblon binding proteins and relationship with response and survival following pomalidomide and dexamethasone in multiple myeloma. Zhu YX et al. Blood. 2014 Jun 9. pii: blood-2014-02-557819. [Epub ahead…
Risk stratification of patients with multiple myeloma prior to autologous stem cell transplantation: what is the role of serum ferritin levels? Shimoni A. Leuk Lymphoma. 2014 May 14:1-7. [Epub ahead of print]. Circulating miRNA markers show promise as new prognosticators for multiple myeloma. Rocci A et al. Leukemia. 2014 May 12. doi: 10.1038/leu.2014.155. [Epub ahead…
Advanced lytic lesion is a poor mobilization factor in peripheral blood stem cell collection in patients with multiple myeloma. Jung SH et al. J Clin Apher. 2014 Apr 25. doi: 10.1002/jca.21326. [Epub ahead of print]. Clinical features, outcome and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the…